The clinical practice of adding antidepressant drugs to the therapy for the eradication of Helicobacter pylori, in addition to the standard drug regimen, has been widely considered in recent years but its specific role in this treatment is still unclear.
In this systematic review researchers tried to establish if there is an association between H. pylori gastritis and depression and to further analyze the therapeutic effect of antidepressants on symptomatic relief in gastritis. For that, they analyzed randomized clinical trials, cross-sectional and prospective studies, and review articles that examined H. pylori infection, depression, functional dyspepsia, and antidepressant treatment. They focused especially on patients whose digestive symptoms did not improve even after successful H. pylori eradication.
Across the studies, a clear pattern emerged: patients with ongoing functional dyspepsia after H. pylori treatment often improved when they were given antidepressants, even when standard eradication therapy alone had not worked. However, the authors highlight that more research is needed before this approach becomes routine medical practice.
Learn more about this review here: https://doi.org/10.7759/cureus.5956
Reference
Al Quraan A M, Beriwal N, Sangay P, et al. (October 21, 2019) The Psychotic Impact of Helicobacter pylori Gastritis and Functional Dyspepsia on Depression: A Systematic Review. Cureus 11(10)